Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Ongoing Initiated Apr 20, 2024 (2 years ago)

Tirzepatide 10 mg/0.5 mL Sterile Solution

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64

Affected NDC 99000-9278-64

Compare with the code on your package — it is the most precise check available.

Drug: Tirzepatide

Recalling firm
Revive Rx LLC dba Revive Rx Pharmacy
NDC code
99000-9278-64
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0511-2024 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week.

Other Tirzepatide recalls

See all

Other recalls by Revive Rx LLC dba Revive Rx Pharmacy

All 2024 recalls
Class I · High risk

Hcg 6

Non-sterility; bacterial contamination identified as Paenibacillus lautus.

Terminated Microbial contamination Revive Rx LLC dba Revive Rx Pharmacy D-0648-2022